ATROPINE DROPS

---

Atropine works by inhibiting the activity of the ciliary muscle, which controls the focusing power of the eye. By relaxing this muscle, atropine reduces the eye's tendency to elongate, a process that causes myopia to worsen over time. With low-dose atropine, the impact on vision is minimal, meaning that it does not significantly affect near vision or daily activities, but still provides the necessary effect to slow the progression of myopia. Studies have shown that children who use low-dose atropine experience slower increases in their myopic prescription, reducing the long-term risks associated with high myopia.

Low-dose atropine has been shown in numerous clinical studies to slow the progression of myopia in children by approximately 30-50%. This can significantly reduce the risk of developing high myopia later in life, which is associated with more serious eye conditions such as glaucoma, cataracts, and retinal detachment. At Fighting Myopia, we carefully monitor progress to ensure the treatment is working effectively and adjust the approach as needed.

Low-dose atropine is most beneficial for:

• Children and teenagers with progressing myopia.
• Parents who prefer a non-invasive treatment as an alternative or supplement to other myopia management options, such as orthokeratology or multifocal contact lenses.

We will assess your child's eye health and myopia progression to determine if low-dose atropine is the right treatment option.

Low-dose atropine is generally very well tolerated with minimal side effects, especially when used at the prescribed dose of 0.05%. Some potential side effects may include:

• Mild blurred near vision: This is temporary and typically does not interfere with daily activities, as the dose is very low.
• Light sensitivity: Since atropine can dilate the pupil, children may experience some sensitivity to bright lights, especially during the initial days of treatment. This typically resolves as the eyes adjust.
• Redness or irritation: In rare cases, some individuals may experience mild eye irritation, but this can be addressed by adjusting the dose or discontinuing use.

We monitor your child’s response to treatment closely and make adjustments to ensure comfort and effectiveness.

The effects of low-dose atropine on myopia progression may take several months to become noticeable. However, with consistent use, patients typically experience a significant slowing of myopia progression over time. Follow-up visits will allow us to track the effectiveness of the treatment and make any necessary adjustments.

Low-dose atropine is typically prescribed as a nightly eye drop. Your child will need to apply the drops to each eye once every night before bed. Consistency is key to achieving the desired results, and we will provide instructions on how to administer the drops properly. It is important to stick to the prescribed regimen to maximize effectiveness.

Yes! Low-dose atropine can be used alongside other myopia management strategies, such as orthokeratology, multifocal contact lenses, or specialized myopia control glasses. In fact, combining approaches may enhance the overall effectiveness of myopia management. During your consultation, we will discuss your child’s specific needs and work together to develop a personalized treatment plan.

Low-dose atropine is typically used for several years, especially if myopia progression continues to be a concern. The treatment may be discontinued once your child’s myopia stabilizes, or as they approach adulthood. We will monitor your child’s eye health and myopia progression closely and adjust the treatment plan accordingly.

Atropine itself is safe and is approved by FDA. Myopia management with low-dose atropine is used off-label, because low-dose atropine is not readily available in the pharmacies and has to be specially made to order. Studies have shown that low-dose atropine is safe for long-term use. The 0.05% concentration has been specifically chosen to provide effective myopia control while minimizing side effects.

If you stop using low-dose atropine, the effects of myopia progression control will gradually diminish, and the myopia may start to worsen again. Therefore, it’s important to continue treatment as long as myopia is progressing. If you choose to discontinue treatment, we will discuss alternative options for managing myopia moving forward.

The cost of Myopia Management is $600 per year (minimum of 2 visits per year, which includes axial length measurements for monitoring of progression of myopia and personalized reports sent every 6 months) plus the cost of low-dose atropine, which is generally affordable compared to other myopia management treatments (~$60 per month through compounding pharmacy). Year 2 and beyond - maintenance fee of $400 (2 visits minimum per year, axial length measurements for monitoring of progression of myopia and personalized reports sent every 6 months).

We are passionate about offering personalized care and the most advanced treatments available for managing myopia. Low-dose atropine is one of the most effective, non-invasive options for controlling myopia progression, and we are here to guide you through every step of the process. Whether you’re concerned about your child’s rapidly progressing myopia or looking for a long-term solution to myopia management, low-dose atropine may be the answer. Contact us today to schedule a consultation and begin your journey to clearer vision and a healthier future for your eyes!